3,4-dihydroxyphenylacetic acid has been researched along with chrysin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antunes, MS; Boeira, SP; Goes, ATR; Jesse, CR; Lobo Ladd, AAB; Lobo Ladd, FV; Luchese, C; Paroul, N | 1 |
| Boeira, SP; Cattelan Souza, L; de Gomes, MG; Del Fabbro, L; Furian, AF; Jesse, CR; Lobo Ladd, AAB; Lobo Ladd, FV; Nunes Arantes, RV; Oliveira, MS; Reis Simionato, A; Rossito Goes, A | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and chrysin
| Article | Year |
|---|---|
Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Dopamine; Flavonoids; Gene Expression Regulation; Homovanillic Acid; Inflammation; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factors; Oxidopamine; Parkinson Disease, Secondary; Random Allocation | 2018 |
Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cognition; Dopamine; Female; Flavonoids; Homovanillic Acid; Lipid Peroxidation; Maze Learning; Mice; Neuroprotective Agents; Nitric Oxide Synthase; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Reactive Oxygen Species | 2019 |